Enterprise Value

92.33M

Cash

309.9M

Avg Qtr Burn

-16.72M

Short % of Float

19.97%

Insider Ownership

0.91%

Institutional Own.

-

Qtr Updated

06/30/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
EDG-5506 Details
Becker Muscular Dystrophy, Duchenne muscular dystrophy

Phase 2

Data readout

EDG-5506 Details
Becker Muscular Dystrophy

Phase 2

Data readout

EDG-5506 Details
Rare diseases, Duchenne muscular dystrophy

Phase 2

Data readout

EDG-5506 Details
Rare diseases, Limb-Girdle Muscular Dystrophy, McArdle disease

Phase 2

Data readout

EDG-5506 Details
Duchenne muscular dystrophy, Rare diseases

Phase 2

Initiation

EDG-7500 Details
Heart disease, Hypertrophic cardiomyopathies

Phase 1

Data readout